Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CETP | P11597 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | UBE2N | P61088 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10030688 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL9056370 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL9056362 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL5888630 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL8097588 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL7868316 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL7868164 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL6266008 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL4658896 | 1.00 | GPR84 (0.50) | GPR84LMNASPHK1FFAR1CYP2D6 | |
| SCHEMBL1697648 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12281068-B2 | Stable formulations of 1-Z-bromoalk-1-ene compounds and use thereof in the manufacture of pheromones | MELCHIOR MATERIAL AND LIFE SCIENCE FRANCE (FR) | 2025-04-22 | — | — | US | disclosed |
| CN-114127035-B | Novel stable formulations of 1-Z-bromo-1-olefin compounds and use thereof for the production of pheromones | 法国梅尔基奥材料与生命科学公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-117603430-A | Light response three-section shape memory polyurethane material and preparation method thereof | 西南石油大学 | 2024-02-27 | — | — | CN | disclosed |
| EP-3997055-B1 | NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES | MELCHIOR MATERIAL & LIFE SCIENCE FRANCE (FR) | 2023-08-23 | — | — | EP | disclosed |
| US-20220259134-A1 | NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES | MELCHIOR MATERIAL AND LIFE SCIENCE FRANCE (FR) | 2022-08-18 | — | — | US | disclosed |
| EP-3997055-A1 | NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES | Melchior Material And Life Science France (FR) | 2022-05-18 | — | — | EP | disclosed |
| US-11028424-B2 | Covalent tethering of functional groups to proteins | PROMEGA CORPORATION (US) | 2021-06-08 | — | — | US | disclosed |
| WO-2021009002-A1 | NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES | MELCHIOR MATERIAL AND LIFE SCIENCE FRANCE (FR) | 2021-01-21 | — | — | WO | disclosed |
| US-10604745-B2 | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule | PROMEGA CORPORATION (US) | 2020-03-31 | — | — | US | disclosed |
| CN-110483247-A | Metal alkoxides powder and preparation method and application | BEIJING GUODA HENGTAI SCIENCE AND TRADE CO LTD | 2019-11-22 | — | — | CN | disclosed |
| US-20040214258-A1 | Covalent tethering of functional groups to proteins | PROMEGA CORPORATION | 2004-10-28 | — | — | US | disclosed |
| WO-2004072232-A9 | COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS | PROMEGA CORP (US) | 2004-10-14 | — | — | WO | disclosed |
| WO-2004072232-A2 | COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS | PROMEGA CORPORATION (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-0882768-B1 | Method for producing of phthalocyanine compound | NIPPON CATALYTIC CHEM IND (JP) | 2001-12-19 | — | — | EP | disclosed |
| US-6034236-A | REACTING A PHTHALONITRILE WITH A METAL OXIDE IN PRESENCE OF A SULFONIC ACID CATALYST | NIPPON SHOKUBAI CO., LTD. (JP) | 2000-03-07 | — | — | US | disclosed |
| EP-0882768-A2 | Method for producing of phthalocyanine compound | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0374885-B1 | Antiretroviral aryloxy substituted furan ketones | MERRELL DOW PHARMA (US) | 1994-05-04 | — | — | EP | disclosed |
| US-5237113-A | Preparation of haloalcohols | BASF ALTIENGESELLSCHAFT (DE) | 1993-08-17 | — | — | US | disclosed |
| US-4977185-A | ALSO EFFECTIVE AGAINST HUMAN T-CELL LEUKEMIA VIRUS | MERRELL DOW PHARMACEUTICALS (US) | 1990-12-11 | — | — | US | disclosed |
| EP-0374885-A1 | Antiretroviral aryloxy substituted furan ketones | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281068-B2 | Stable formulations of 1-Z-bromoalk-1-ene compounds and use thereof in the manufacture of pheromones | OR51E2, ARRB1, BDKRB1 | GPR84 742/4885LMNA 3609/4885SPHK1 1023/4885 |
| US-20220259134-A1 | NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES | OR51E2, ARRB1, BDKRB1 | GPR84 698/4885LMNA 3487/4885SPHK1 1008/4885 |
| US-10604745-B2 | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule | HDHD5, DDT, DDAH1 | GPR84 959/4885LMNA 4375/4885SPHK1 4798/4885 |
| US-11028424-B2 | Covalent tethering of functional groups to proteins | GGT1, HDHD5, DNPH1 | GPR84 2459/4885LMNA 3765/4885SPHK1 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.